Pfizer Inc. (ETR:PFE)
21.51
-0.38 (-1.71%)
Oct 10, 2025, 5:35 PM CET
Pfizer Revenue
Pfizer had revenue of $14.65B USD in the quarter ending June 29, 2025, with 10.31% growth. This brings the company's revenue in the last twelve months to $63.83B, up 13.54% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$63.83B
Revenue Growth
+13.54%
P/S Ratio
2.22
Revenue / Employee
$788.06K
Employees
81,000
Market Cap
121.21B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | 40.83B | -11.72B | -22.31% |
Dec 31, 2017 | 52.55B | -278.00M | -0.53% |
Dec 31, 2016 | 52.82B | 3.97B | 8.13% |
Dec 31, 2015 | 48.85B | -754.00M | -1.52% |
Dec 31, 2014 | 49.61B | -1.98B | -3.84% |
Dec 31, 2013 | 51.58B | -3.07B | -5.62% |
Dec 31, 2012 | 54.66B | -6.38B | -10.45% |
Dec 31, 2011 | 61.04B | -4.13B | -6.34% |
Dec 31, 2010 | 65.17B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Pfizer News
- 20 hours ago - Lower drug prices for Americans! Trump seals deal with AstraZeneca; some medicines at discounts of up to 80% - The Times of India
- 1 day ago - Biotech Stocks Have Struggled Since 2021. Why They're Coming Back. - Barrons
- 1 day ago - AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs - The Guardian
- 1 day ago - AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market. - MarketWatch
- 1 day ago - AstraZeneca to follow Pfizer lead in making drug price deal with Trump - report - Seeking Alpha
- 1 day ago - Pfizer (PFE) Target Price Lowered by Morgan Stanley | PFE Stock News - GuruFocus
- 1 day ago - Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports - CNBC
- 1 day ago - FDA Gives Tentative Nod to Sandoz's Generic Version of Pfizer's Inlyta - GuruFocus